How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Profit-taking drags on Bursa Malaysia on first day of 2026 trading
Enra inks JVs to develop RM101.26mil GDV of residential homes in Kulai
Vetece unit to provide HCM cloud software for RM12.6mil
Britain's FTSE-100 index hits 10,000 mark for first time
Bursa Malaysia derivatives hit annual volume high for 2nd consecutive year
PUNB appoints Rastam Mohd Isa as new chairman
Hong Kong stocks start 2026 strong on tech rally
Bursa Malaysia ends morning sessions lower
Kenanga IB maintains 2025 growth forecast at 4.8%
Pekat subsidiary bags RM113.31mil TNB contract

Others Also Read